Search results
Unveiling SEHK Growth Leaders With High Insider Ownership In June 2024
Simply Wall St. via Yahoo Finance· 1 day agoAmidst a backdrop of fluctuating global markets, the Hong Kong stock market has shown resilience,...
NIAID is 'on the ball' with H5N1 research, but gaps in bird flu prevention remain: experts
FierceBiotech· 14 hours agoAgainst a backdrop of low-volume but growing concerns about bird flu, the National Institutes of...
Hong Kong may reduce quarantine for imported pets but animals must be vaccinated
South China Morning Post· 6 days ago“As biotechnology has developed in recent years, the Agriculture, Fisheries and Conservation...
HKSTP Showcases Top Biotech Innovations and Attracts Global Enterprises at US BIO 2024
Digital Journal· 7 days ago...Newswire 16 top-tier Park companies present their cutting-edge research, products and services, including a debut of InnoHKs Centre for Chinese Herbal Medicine Drug Development in the international arena HONG KONG SAR - Media OutReach Newswire - 4 June 2024 - The Hong Kong Science and Technology...
Has the shadow of Covid finally departed for travel?
The Independent US via AOL· 2 days agoUntil this weekend, a Qantas passenger who happened to doze off during the 800-mile flight from Darwin to Alice Springs could be forgiven for thinking...
HUTCHMED Initiates Phase I Trial of Menin Inhibitor HMPL-506 in Patients with Hematological...
Benzinga· 4 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited ("HUTCHMED") (Nasdaq/AIM:HCM; HKEX:13) today announces ...
‘My whole skull was throbbing’: How it feels to survive bird flu
The Telegraph via Yahoo News· 9 hours agoIt sounds like something out of a science fiction film but clade 2.3.4.4b, as the latest major...
Hong Kong to face healthcare manpower crunch in 2030, health authorities say
South China Morning Post· 3 days ago“The supply of doctors will continue to be limited in the short to long term compared with...
Healthcare cost woes dampen Filipinos’ financial confidence - BusinessWorld Online
BusinessWorld· 8 hours agoThe survey was conducted online in January and February and covered a total of 8,400 individuals...
FDA accepts filing of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of...
Benzinga· 21 hours agoBioArctic AB's (publ) (NASDAQ Stockholm: BIOA B) partner Eisai announced today that that the U.S. Food and Drug Administration (FDA) has accepted Eisai's Supplemental Biologics License Application ...